Osteoporosis Clinical Trials

Showing 601-620 of 690 trials

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

NCT00176579

RATIONALE: Measuring bone mineral density may help doctors predict whether prostate cancer will come back. It may also help the study of prostate cancer in the future. PURPOSE: This clinical trial is studying whether bone mineral density affects cancer recurrence in patients with early stage prostate cancer.

OsteoporosisProstate Cancer

University of Medicine and Dentistry of New Jersey27 participantsStarted Jun 2003

New Brunswick, New Jersey, United States

COMPLETEDPhase 2

Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation

NCT00143273

To establish the optimal dose of lasofoxifene that is fully effective in increasing the BMD in postmenopausal Asian women.

Osteoporosis

Ligand Pharmaceuticals497 participantsStarted Jun 2004

Fukuoka, Fukuoka, Japan • Kagoshima, Kagoshima-ken, Japan • Kagoshima, Kagoshima-ken, Japan +14 more locations

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation

Related Searches

The Impact of a Structured Physical Activity Program on Bone Strength and Psycho-Motor Learning of Young Children

Study of Transitioning From Alendronate to Denosumab

Nutritional Problems After Lung and Heart Transplantation

The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa

Low Energy Availability, Menstrual Irregularity, and Low Bone Mass

Back Pain in Patients With Severe Osteoporosis

Does Bone Structure Explain the Increased Fracture Risk in Type II Diabetes Patients? A Pilot Study

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women

Improving Quality of Osteoporosis Care Through Patient Storytelling

Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density

Longitudinal Assessment of Bone Growth in Children With Cerebral Palsy

Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis

A School-Based Osteoporosis Prevention Program for Adolescent Girls